Human Serum Attenuates the Activity of Protease Inhibitors toward Wild-Type and Mutant Human Immunodeficiency Virus-Reference-Cited by-同舟云学术

Human Serum Attenuates the Activity of Protease Inhibitors toward Wild-Type and Mutant Human Immunodeficiency Virus

Published:1998-10 Issue:2 Volume:250 Page:255-262
ISSN:0042-6822
Container-title:Virology
language:en
Short-container-title:Virology

Author:

Molla Akhteruzzaman,Vasavanonda Sudthida,Kumar Gondi,Sham Hing L.,Johnson Marianne,Grabowski Brian,Denissen Jon F.,Kohlbrenner William,Plattner Jacob J.,Leonard John M.,Norbeck Daniel W.,Kempf Dale J.

Publisher

Elsevier BV

Subject

Virology

Reference30 articles.

1. Reduction of the in vitro activity of A77003, an inhibitor of human immunodeficiency virus protease by human serum α1;Bilello;J. Infect. Dis.,1995

2. Human serum α1;Bilello;Antimicrob. Agents Chemother.,1996

3. Protein binding and kinetics of drug in liver diseases;Blaschke;Clin. Pharmacokinet.,1977

4. Penetration of ampicillin and dicloxacillin into tissue case fluid in rabbits: Relation to serum and tissue protein binding;Cars;Scand. J. Infect. Dis.,1981

5. The median-effect principle and the combination index for quantitation of synergism and antagonism;Chou,1991

Cited by 173 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nutritional Composition of Dry Fish: An Overview;Dry Fish: A Global Perspective on Nutritional Security and Economic Sustainability;2024

2. Novel wild type and mutate HIV-1 protease inhibitors containing heteroaryl carboxamides in P2: Synthesis, biological evaluations and in silico ADME prediction;Results in Chemistry;2023-12

3. Synthetic Attempts Towards Eminent Anti-viral Candidates of SARS-CoV;Mini-Reviews in Medicinal Chemistry;2022-02

4. Toward Consensus on Correct Interpretation of Protein Binding in Plasma and Other Biological Matrices for COVID‐19 Therapeutic Development;Clinical Pharmacology & Therapeutics;2020-11-21

5. A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19;Nature Communications;2020-10-15